Skip to main content
. 2021 Aug 14;13(8):1258. doi: 10.3390/pharmaceutics13081258

Table 1.

Acquisition parameters employed in the MRI studies.

Object Type TR 1 (ms) TE 2 (ms) Av 3 FOV 4 (mm2) Acq 5 Resolution (μm3) Additional
Parameters
Phantom 6 T2WI 3000 23 3 40 × 40 3 min 36 s 156 × 156 × 1000 RARE 8 = 8
T2 maps 5000 12 1 40 × 40 10 min 40 s 312 × 312 × 1000 NE 9 = 50, RARE = 8
Mouse-body 6 T2WI 11,12 1000 17 3 40 × 40 2 min 27 s 156 × 156 × 1000 RARE = 4
T2 maps 11 3000 7 1 40 × 40 6 min 42 s 312 × 312 × 1000 NE = 32, RARE = 8
Dynamic 11 1000 16 1 40 × 40 32 min 312 × 312 × 1000 NR 10 = 60, RARE = 4
Mouse-head 7 T2WI 12 2500 26 4 23 × 23 4 min 90 × 90 × 1000 RARE = 8
T2 maps 12 3000 7 1 23 × 23 6 min 42 s 180 × 180 × 1000 NE = 32, RARE = 8
Dynamic 12 1000 16 1 23 × 23 32 min 180 × 180 × 1000 NR 10 = 60, RARE = 4

1 TR: repetition time; 2 TE: echo time; 3 Av: averages; 4 FOV: field of view; 5 Acq: acquisition time; 6 studies performed with the 40 mm birdcage resonator; 7 studies performed with the 23 mm surface coil; 8 RARE: acceleration factor; 9 NE: number of echoes; 10 NR: number of repetitions; 11 Acquisitions performed in coronal orientation, 12 Acquisitions performed in axial orientation.